Novel virus-like particle vaccine immunogenic against chikungunya virus
1. A novel vaccine based on virus-like particles (VLPs) was immunogenic and well-tolerated against chikungunya virus. Evidence Rating Level: 2 ...
1. A novel vaccine based on virus-like particles (VLPs) was immunogenic and well-tolerated against chikungunya virus. Evidence Rating Level: 2 ...
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.